SimCardioTest

an international project

10
Organisations
6
Countries worldwide
8M €
Funded by EU H2020
10
Organisations
6
Countries worldwide
8M €
Funded by EU H2020

SimCardioTest

an international project

9
Organisations
5
Countries worldwide
8M €
Funded by EU H2020
SimCardioTest is a European Union Horizon 2020 (EU H2020) project for research and innovation in the area of Digital transformation in Health and Care (DTH), and funded by the European Commission for the period of January 2021 ─ December 2024 (Grant Agreement N°101016496). The official name of the project is “Simulation of Cardiac Devices & Drugs for in-silico Testing and Certification”, which is also the focus area of our research activities. The name “SimCardioTest” is an amalgam of “Simulation”, “Cardiac” and “Testing”.
EU H2020

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them. 

SIMCARDIOTEST PUBLICATIONS & OTHER RESOURCES 

Access our papers (2021-2025)

Strong teams backing up

The best experts in the field working together

SimCardioTest is a collaborative project between 10 organizations from 6 European countries and United States funded by the European Commission (EU H2020). This project will provide new insight into designing new predictive tools in cardiac pathologies and will accelerate the uptake of computer simulations for testing medicines and medical devices.​

Meet our partners

Keypoints

Everything about our goals, methodologies and procedures

objective-icon

Objectives

In-silico methods, together with high-performance computing infrastructures, the increasing availability of patient-specific data and big data analysis has the potential to bring clinical trials to the 21st century.

case-icon

Use cases

A standardised and secure cloud-based platform will be developped where in-silico trials will run seamlessly. Three cardiac use cases will demonstrate the platform effectiveness to test devices and drugs.

@INRIA / ASCLEPIOS – Calculation mesh of the 4 cardiac chambers

regulate-icon

Regulation

SimCardioTest will be conducted closely with the regulatory institutions as the results of the simulations can support a verified certification process.

exploit-icon

Exploitation

The exploitation potential of SimCardiotest outcomes on targeted EU and US markets will be assessed . The market sectors involved in the potential business opportunities for the system developed will be analysed.

Video @Inria: Introduction to SimCardioTest

have any questions about us?

Don't hesitate to contact us

comm-icon
Communication details
question-icon
General questions